Discover
NAUT
Nautilus Biotechnology, Inc.
1.84
2 x 1.43
2 x 2.40
bid
ask
-
0.03
1.60%
2 @ 04:00 PM
1.80 -0.04 (2.17%)
| Ytd | -5.64% | |
| 1y | 152.05% |
1.83
day range
2.00
0.62
52 week range
4.31
| Open | 1.88 | Prev Close | 1.87 | Low | 1.83 | High | 2.00 | Mkt Cap | 233.83M |
| Vol | 2.35M | Avg Vol | 558.90K | EPS | -0.46 | P/E | N/A | Forward P/E | -2.32 |
| Beta | 1.04 | Short Ratio | 9.26 | Inst. Own | 50.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 2.50 | 200-d Avg | 2.15 | 1yr Est | 3.44 |
| Income Statement | |||
| Operating Expenses | 16.12M | ||
| Research and Development Expense | 9.71M | ||
| Selling, General and Administrative Expense | 6.42M | ||
| Operating Income | -16.12M | ||
| Net Income | -14.70M | ||
| Net Income Common Stock | -14.70M | ||
| Net Income Common Stock (USD) | -14.70M | ||
| Consolidated Income | -14.70M | ||
| Earnings per Basic Share | -0.12 | ||
| Earnings per Basic Share (USD) | -0.12 | ||
| Earnings per Diluted Share | -0.12 | ||
| Earning Before Interest & Taxes (EBIT) | -14.70M | ||
| Earning Before Interest & Taxes (USD) | -14.70M | ||
| Weighted Average Shares | 126.63M | ||
| Weighted Average Shares Diluted | 126.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.63M | ||
| Cash and Equivalents (USD) | 14.63M | ||
| Investments | 128.75M | ||
| Investments Current | 81.24M | ||
| Investments Non-Current | 47.51M | ||
| Current Assets | 98.83M | ||
| Property, Plant & Equipment Net | 30.27M | ||
| Total Assets | 177.78M | ||
| Debt Current | 3.85M | ||
| Total Debt | 28.87M | ||
| Current Liabilities | 8.34M | ||
| Debt Non-Current | 25.02M | ||
| Total Liabilities | 33.36M | ||
| Accumulated Retained Earnings (Deficit) | -346.72M | ||
| Accumulated Other Comprehensive Income | -91.00K | ||
| Shareholders Equity | 144.42M | ||
| Shareholders Equity (USD) | 144.42M | ||
| Assets Non-Current | 78.95M | ||
| Total Debt (USD) | 28.87M | ||
| Liabilities Non-Current | 25.02M | ||
| Trade and Non-Trade Payables | 1.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.48M | ||
| Net Cash Flow from Financing | 1.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.24M | ||
| Capital Expenditure | -510.00K | ||
| Issuance (Purchase) of Equity Shares | 1.11M | ||
| Net Cash Flow from Investing | 14.23M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.74M | ||
| Net Cash Flow from Operations | -13.10M | ||
| Share Based Compensation | 1.36M | ||